Your trusted destination for CME, CPD & Medical Education across the Middle East.
The master class will focus on contemporary hematology, covering malignant and non-malignant blood disorders and their diagnostic and therapeutic management. Topics will include leukemia, lymphoma, myeloma, myelodysplastic and myeloproliferative disorders, anemia, coagulation and platelet disorders, thrombosis, molecular diagnostics, targeted therapies, immunotherapy, and cellular medicine.
The 4th Middle East Master Class in Hematology (MEMAC 2027) will bring together hematologists, oncologists, transfusion medicine specialists, laboratory professionals, researchers, and other healthcare practitioners to discuss advances in the diagnosis and management of hematological disorders. The master class will provide a focused educational platform addressing contemporary approaches to malignant and non-malignant hematology. Key discussions will cover leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, myeloproliferative neoplasms, and other hematologic malignancies. The program will also address anemia, bleeding and coagulation disorders, thrombosis, platelet disorders, and other common hematological conditions. Participants will explore advances in molecular diagnostics, targeted therapies, immunotherapy, cellular therapies, and precision medicine in hematological disease. The scientific sessions will incorporate challenging clinical cases and multidisciplinary perspectives to support evidence-based diagnosis, treatment selection, and patient management. Through expert lectures, interactive case discussions, and knowledge exchange, MEMAC 2027 will highlight evolving strategies and innovations shaping modern hematology practice.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow